Skip to main content

Table 2 Association of lncRNA RGMB-AS1 and RGMB expression with clinicopathologic features of NSCLC patients

From: Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer

Clinicopathological factor n LncRNA RGMB-AS1 expression(2–ΔCt) RGMB mRNA expression(2–ΔCt)
   Median ± SD P Media ± SD P
Gender      
Male 47 0.0734 ± 0.0641 0.847 0.4148 ± 0.2016 0.301
Female 25 0.0763 ± 0.0557   0.3656 ± 0.1684  
Age(years)      
≥60 28 0.0634 ± 0.0638 0.226 0.4320 ± 0.2111 0.227
<60 44 0.0814 ± 0.0587   0.3759 ± 0.1761  
Histology      
SCC 44 0.0718 ± 0.0584 0.662 0.4020 ± 0.1989 0.812
Adeno 28 00784 ± 0.0656   0.3909 ± 0.1813  
Differentiation      
Well 16 0.0269 ± 0.0323 0.007* 0.5292 ± 0.1771 0.032*
Moderate 39 0.0556 ± 0.0378   0.4299 ± 0.1633  
Poor 17 0.1622 ± 0.0281   0.2000 ± 0.0883  
Lymphnode metastasis      
Positive 37 0.1146 ± 0.0514 0.000* 0.3169 ± 0.1640 0.000*
Negative 35 0.0319 ± 0.0367   0.4832 ± 0.1819  
TNM      
I + II 31 0.0265 ± 0.0326 0.000* 0.5068 ± 0.1751 0.007*
III + IV 41 0.1106 ± 0.0517   0.3152 ± 0.1598  
  1. SCC: Squamous cell carcinoma; Adeno: Adenocarcinoma
  2. *Indicated statistical significance (P < 0.05)